Get the Stockscreener App
0.791
1.89%
0.0147
iBio Inc stock is traded at $0.791, with a volume of 410.02K.
It is up +1.89% in the last 24 hours and up +7.53% over the past month.
iBio, Inc., a biotechnology company, provides product development and manufacturing services to clients, collaborators, and third-party customers in the United States and internationally. The company's services cover the stages of product selection, regulatory approval, and commercial product launch. Its lead therapeutic candidate is IBIO-CFB03 for the treatment of systemic scleroderma, idiopathic pulmonary fibrosis, and other fibrotic diseases. It is also developing vaccine candidates for third parties. The company has collaboration agreements with ONEWAY Diagnostica; AzarGen Biotechnologies (Pty) Ltd; The Texas A&M University System; and Fraunhofer Center for Molecular Biotechnology, as well as strategic relationship with CC-Pharming Ltd. In addition, it offers a range of product and process development, analytical, and manufacturing services. iBio, Inc. is headquartered in New York, New York.
See More
Previous Close:
$0.7763
Open:
$0.744
24h Volume:
410.02K
Relative Volume:
0.21
Market Cap:
$12.83M
Revenue:
$2.05M
Net Income/Loss:
$-23.15M
P/E Ratio:
-0.1193
EPS:
-6.6319
Net Cash Flow:
$-16.93M
1W Performance:
+6.72%
1M Performance:
+7.53%
6M Performance:
-77.27%
1Y Performance:
-60.55%
1-Day Range:
$0.744
$0.8189
1-Week Range:
$0.67
$0.8189
52-Week Range:
$0.5562
$6.8908
iBio Inc Stock (IBIO) Company Profile
Name
iBio Inc
Sector
Industry
Phone
302-355-0650
Address
600 Madison Avenue, Suite 1601, New York, NY
Compare IBIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IBIO
iBio Inc
|
0.791 | 12.05M | 2.05M | -23.15M | -16.93M | -6.6319 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
iBio Inc Stock (IBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-28-24 | Initiated | Chardan Capital Markets | Buy |
| Nov-29-21 | Initiated | JMP Securities | Mkt Outperform |
| Jan-22-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-26-20 | Initiated | Alliance Global Partners | Buy |
iBio Inc Stock (IBIO) Latest News
iBio prices $50 million public offering of warrants for antibody research By Investing.com - Investing.com South Africa
Day One Biopharmaceuticals, Inc. shares rise 1.62% intraday after iBio, Inc. announced a public offering of pre-funded warrants. - AInvest
iBio prices $50 million public offering of warrants for antibody research - Investing.com
iBio Announces Pricing of $50 Million Public Offering - The Manila Times
$50 Million Fundraise: AI-Driven Biotech iBio Secures Major Financing for Breakthrough Drug Programs - Stock Titan
IBio Launches Public Offering to Advance Preclinical Pipeline - MarketScreener
iBio Highlights Advancements in Obesity Pipeline - TipRanks
iBio Reports Q2 FY23 Adj. Rev. Down 12% YoY - AInvest
iBio Announces Proposed Public Offering | IBIO Stock News - GuruFocus
iBio announces public offering to fund cardiometabolic programs - Investing.com
iBio Announces Proposed Public Offering - The Manila Times
Biotech iBio Unveils Strategic Public Offering to Accelerate Development of IBIO-610 and IBIO-600 Programs - Stock Titan
iBio Inc. Inches Toward Key Resistance — Will It Break2025 Breakouts & Breakdowns & Weekly High Conviction Ideas - newsyoung.net
Traders Consider Averaging Down in iBio Inc.Earnings Recap Report & Smart Investment Allocation Tips - kangso.co.kr
Watch for Bullish Crossover in IBIOInsider Buying & Risk Controlled Daily Plans - sundaytimes.kr
Is iBio Inc. stock bottoming outShare Buyback & Accurate Entry and Exit Point Alerts - Newser
Can technical indicators confirm iBio Inc.’s reversal2025 Analyst Calls & Free Community Supported Trade Ideas - Newser
iBio Inc. stock trendline breakdownJuly 2025 Review & Entry Point Confirmation Signals - Newser
Building trade automation scripts for iBio Inc.Weekly Investment Report & Stock Portfolio Risk Management - Newser
iBio Inc. Stock Lags Behind Sector BenchmarksWeekly Market Summary & Weekly Setup with ROI Potential - thegnnews.com
iBio Inc’s Shares Reel: -8.88% Quarterly Revenue Decline Amid 11.83M Market Cap - investchronicle.com
What institutions are buying iBio Inc. stock nowQuarterly Portfolio Review & Risk Managed Investment Strategies - Newser
Smart tools for monitoring iBio Inc.’s price actionTrade Plan With Low Risk High Return - Newser
Will iBio Inc. benefit from AI trendsStocks Poised for 300% Growth - 뉴스임팩트
Identifying reversal signals in iBio Inc.Free Investment Playbook for Growing Markets - Newser
Analyzing iBio Inc. with risk reward ratio chartsFree Daily Momentum Screener With Alerts - Newser
Using Bollinger Bands to evaluate iBio Inc.Buy Signal Forecast With Short-Term Data - Newser
What’s next for iBio Inc. stock priceHigh Confidence Strategy with Trend Alignment - Newser
Price Floor Holding on iBio Inc. — Rebound PossibleTarget Return Focused Trade Insights Shared - metal.it
Can iBio Inc. expand its profit marginsFree Buy and Hold Suggestions - thegnnews.com
iBio Inc. Company Revenue and Profit Trends: A Deep DivePredictive AI Signals for Short-Term Trading - Newser
Is iBio Inc. Stock a Good Fit for Conservative InvestorsFundamental + Technical Hybrid Stock Tips Shared - metal.it
What are the technical indicators suggesting about iBio Inc.Exceptional market positioning - Jammu Links News
What makes iBio Inc. stock price move sharplyInvest confidently with market-leading analysis - Jammu Links News
What are analysts’ price targets for iBio Inc. in the next 12 monthsBuild wealth faster with consistent growth stocks - Jammu Links News
Is iBio Inc. stock overvalued or undervaluedGet daily expert analysis on top stocks - Jammu Links News
How does iBio Inc. generate profit in a changing economyDiscover stocks with explosive upside potential - Jammu Links News
What institutional investors are buying iBio Inc. stockAchieve breakthrough performance with smart picks - Jammu Links News
How volatile is iBio Inc. stock compared to the marketConsistent double returns - Jammu Links News
Is it the right time to buy iBio Inc. stockStay ahead with daily expert stock picks - Jammu Links News
Will earnings trigger a reversal in iBio Inc.AI Pattern Recognition and Trade Prediction - Newser
Ibio Faces Nasdaq Delisting Notice: What to Know - AInvest
What is IBIO company’s growth strategyCapitalize on market trends with confidence - Jammu Links News
What are the latest earnings results for iBio Inc.Achieve rapid wealth accumulation through smart investing - Jammu Links News
What analysts say about iBio Inc. stockUnlock high-yield investment opportunities - Jammu Links News
iBio Faces Nasdaq Delisting Notice for Stock Price - The Globe and Mail
iBio Inc. Building a Base Near SupportFundamental Growth Stock Analysis Shows Strength - metal.it
iBio receives Nasdaq notice for minimum bid price deficiency By Investing.com - Investing.com Australia
iBio receives Nasdaq notice for minimum bid price deficiency - Investing.com
Can iBio Inc. Rally Enough to Break EvenLong Hold Safe Return Strategy Reviewed - metal.it
Why iBio Inc. stock attracts strong analyst attentionROI Driven Equity Selection With Safety Emphasized - metal.it
iBio Inc Stock (IBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):